WuXi Biologics’ Acquisition of Bayer Biologics And COVID-19 Vaccines Facility

Federica Tiefenthaler
Tagged:

Heuking Kühn Lüer Wojtek advised WuXi Biologics on this transaction.Globally operating Chinese group WuXi Biologics completed the acquisition of a drug substance facility from Bayer AG…

This content is for Standard 1 Year members only.
Login Join Now
Federica Tiefenthaler

Author: Federica Tiefenthaler

…

This content is for Standard 1 Year members only.
Login Join Now